NCT00115089View on ClinicalTrials.gov

7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

September 30, 2005

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

R926112

DRUG

Beclomethasone dipropionate

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY